AbbVie Aktie
168,58
EUR
+1,42
EUR
+0,85
%
175,51
USD
-0,19
USD
-0,11
%
nachbörslich
AbbVie Aktie Analyse
| 27.06.19 | AbbVie Peer Perform | Wolfe Research | |
| 29.04.19 | AbbVie Market Perform | BMO Capital Markets | |
| 26.12.18 | AbbVie Buy | Standpoint Research | |
| 02.02.18 | AbbVie Underperform | BMO Capital Markets | |
| 25.09.17 | AbbVie Neutral | UBS AG | |
| 15.03.16 | AbbVie Hold | Deutsche Bank AG | |
| 01.12.15 | AbbVie Equal weight | Barclays Capital | |
| 23.10.15 | AbbVie Buy | UBS AG | |
|
Werbung
|
|||
| 17.04.15 | AbbVie Outperform | BMO Capital Markets | |
| 06.01.15 | AbbVie Buy | UBS AG | |
| 26.11.14 | AbbVie Buy | Argus Research Company | |
| 14.11.14 | AbbVie Buy | Deutsche Bank AG | |